about
P53 functional abnormality in mesenchymal stem cells promotes osteosarcoma developmentMicroRNAs and Potential Targets in Osteosarcoma: ReviewThe Effect of MicroRNA-124 Overexpression on Anti-Tumor Drug SensitivityMesenchymal stromal cells promote tumor progression in fibrosarcoma and gastric cancer cellsEpidemiology and therapies for metastatic sarcomaPrognostic role of CD44 expression in osteosarcoma: evidence from six studies.Single nucleotide polymorphisms in VEGF gene are associated with an increased risk of osteosarcoma.Focal chromosomal copy number aberrations identify CMTM8 and GPR177 as new candidate driver genes in osteosarcoma.Correlation of WWOX, RUNX2 and VEGFA protein expression in human osteosarcomaQuantitative assessment of the association of COX-2 (Cyclooxygenase-2) immunoexpression with prognosis in human osteosarcoma: a meta-analysis.Whole exome sequencing of a single osteosarcoma case--integrative analysis with whole transcriptome RNA-seq data.Stress response gene activation protects sea urchin embryos exposed to X-rays.Single nucleotide polymorphisms of nucleotide excision repair and homologous recombination repair pathways and their role in the risk of osteosarcomaMesenchymal stromal cells of osteosarcoma patients do not show evidence of neoplastic changes during long-term culture.Effect of variation of FGF2 genotypes on the risk of osteosarcoma susceptibly: a case control study.At-risk populations for osteosarcoma: the syndromes and beyond.Occurrence of Comorbidities before and after Soft Tissue Sarcoma DiagnosisAssociations of IL-27 polymorphisms and serum IL-27p28 levels with osteosarcoma risk.P2X7 Receptor Function in Bone-Related Cancer.Association between XRCC3 Thr241Met polymorphism and risk of osteosarcoma in a Chinese population.Characterization of the metastatic phenotype of a panel of established osteosarcoma cells.Amphiregulin enhances intercellular adhesion molecule-1 expression and promotes tumor metastasis in human osteosarcomaPTH prevents the adverse effects of focal radiation on bone architecture in young ratsMiR-34a and miR-203 Inhibit Survivin Expression to Control Cell Proliferation and Survival in Human Osteosarcoma CellsCharacterization of FGFR signaling pathway as therapeutic targets for sarcoma patientsOverexpression of KH-type splicing regulatory protein regulates proliferation, migration, and implantation ability of osteosarcoma.Role of the WWOX tumor suppressor gene in bone homeostasis and the pathogenesis of osteosarcoma.The association of glutathione S-transferase polymorphisms in patients with osteosarcoma: evidence from a meta-analysis.Significance of MTA1 in the molecular characterization of osteosarcoma.Pharmacological inhibition of Bcl-xL sensitizes osteosarcoma to doxorubicin.Osteosarcoma: Molecular Pathogenesis and iPSC Modeling.The IGF-1R/AKT pathway has opposing effects on Nutlin-3a-induced apoptosis.MicroRNA-497 suppresses osteosarcoma tumor growth in vitro and in vivo.The predictive potential and oncogenic effects of HOXC8 expression on osteosarcoma.Activation of the MAPK/Akt/Nrf2-Egr1/HO-1-GCLc axis protects MG-63 osteosarcoma cells against 15d-PGJ2-mediated cell death.Genetic factors conferring metastasis in osteosarcoma.Lentivirus-mediated RNA interference targeting UbcH10 reduces cell growth and invasion of human osteosarcoma cells via inhibition of Ki-67 and matrix metalloproteinases.MicroRNA-144 inhibits the proliferation, apoptosis, invasion, and migration of osteosarcoma cell line F5M2.Molecular genetics of osteosarcoma.Inorganic phosphate enhances sensitivity of human osteosarcoma U2OS cells to doxorubicin via a p53-dependent pathway.
P2860
Q26771603-275CA3D1-ED1C-4A2B-BE49-05F142710880Q26784033-81559DF9-2F91-4868-AB42-3509CB2156F2Q28545860-9BF10AC0-A1C7-40FF-A84C-A523DBFE0165Q33864981-47EB4FC0-736E-42FE-B8C7-2085270ED677Q34652142-7B9D315F-B8DE-4193-9AB2-3B0479C0C411Q34668490-01F39076-D2AD-4556-9551-899F6ED9188FQ34733144-ACDB91C9-C115-4A03-B040-E3FED6491BCDQ34797092-5BCD5415-BF14-4EBC-923F-AC812B0690E0Q35065555-7309DD68-BA49-4573-9792-1A35565A427DQ35072942-5BC10C21-DE31-4B45-8D99-A54400DA3C9DQ35511058-B4FF40F1-B693-4B0E-B3C7-3B3D759AE61CQ35562252-A0A3203A-1A3A-49A9-8154-356F82AD3CE4Q35765827-691BAC91-1FFF-4A69-88CB-9F1F8100CAE4Q35770479-C5563596-F75B-4526-91B7-1854DB7E5D26Q35791674-FD858B5F-C12E-49FC-8A29-9CAEB52C0698Q35897747-8AE2F87A-A98A-407F-8730-E14FD0ED27F7Q36012079-C6E50AE7-CAA4-440D-958F-5088B674CE52Q36193602-0A00D15C-E2A4-47E8-9312-6F0A94131406Q36200053-D3A8398B-4BE1-422A-A830-69789CB08EAAQ36262010-6D8BC008-C6B5-4736-83FE-293B6EB23075Q36557338-6F94A90F-E7CE-4EFA-8FE3-8040C6E82366Q36562200-DFC24962-FF34-4F38-9356-832550D055BCQ36920155-C149BCA0-C3F0-4A9B-AF2E-4DD512966907Q37015713-6D013F88-B86A-4E4C-81CA-72A6A4BCEFDCQ37094042-FCFEF7FC-B13D-44D3-B7B8-2DD77B27F6E7Q37103971-41290648-4FFD-4239-831D-ED47725D5D97Q37897986-722F6933-FFF1-40A3-8B64-C75F8252F151Q38201140-CBBA17DD-4BCB-4CC8-8A43-3E7F6DD92D91Q38260257-289CD2E5-8908-4AFB-B186-8173CBA132C0Q38262894-0769C018-5378-4898-B2CD-0E6323D8249FQ38653083-67C562F9-0D46-4F0E-81A3-18B98971E8D9Q38697577-4EA3825D-28F0-4644-B6F4-C35941382EF2Q38720897-F0B12D52-E64E-4AEF-B0D2-D45523418571Q38744613-5B0E294F-4685-4807-83A5-CDB7AC45A18CQ38800299-2DF4A788-775F-4D8D-BB71-BE2BB2EA1009Q38806986-0941C1A4-1F95-4D9A-8FED-4C217A986966Q38857320-62E4004F-1ADD-4106-B045-A96F127F7C4FQ38889691-1BA10A82-1C2E-4015-BC09-BCC2E001E837Q38985480-E42247D9-49C1-4F0A-9C6E-EC8EDEB737CBQ39335691-6888590B-4F60-4316-94C6-9AF78117F2AE
P2860
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
The etiology of osteosarcoma.
@en
The etiology of osteosarcoma.
@nl
type
label
The etiology of osteosarcoma.
@en
The etiology of osteosarcoma.
@nl
prefLabel
The etiology of osteosarcoma.
@en
The etiology of osteosarcoma.
@nl
P1476
The etiology of osteosarcoma.
@en
P2093
Norman Jaffe
P356
10.1007/978-1-4419-0284-9_2
P577
2009-01-01T00:00:00Z